BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25151255)

  • 1. Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma.
    Leggett CL; Lewis JT; Wu TT; Schleck CD; Zinsmeister AR; Dunagan KT; Lutzke LS; Wang KK; Iyer PG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):658-64.e1-3. PubMed ID: 25151255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.
    Schmidt HM; Mohiuddin K; Bodnar AM; El Lakis M; Kaplan S; Irani S; Gan I; Ross A; Low DE
    Surg Endosc; 2016 Aug; 30(8):3391-401. PubMed ID: 26541725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.
    Prasad GA; Wu TT; Wigle DA; Buttar NS; Wongkeesong LM; Dunagan KT; Lutzke LS; Borkenhagen LS; Wang KK
    Gastroenterology; 2009 Sep; 137(3):815-23. PubMed ID: 19524578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
    Kamboj AK; Goyal R; Vantanasiri K; Sachdeva K; Passe M; Lansing R; Garg N; Chandi PS; Ramirez FC; Kahn A; Fukami N; Wolfsen HC; Krishna M; Pai RK; Hagen C; Lee HE; Wang KK; Leggett CL; Iyer PG
    Am J Gastroenterol; 2024 Apr; 119(4):662-670. PubMed ID: 37795907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
    Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
    Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
    Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
    Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units.
    Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC
    Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotherapy for superficial adenocarcinoma of the esophagus: an American experience.
    Saligram S; Chennat J; Hu H; Davison JM; Fasanella KE; McGrath K
    Gastrointest Endosc; 2013 Jun; 77(6):872-6. PubMed ID: 23472998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.
    Wani S; Abrams J; Edmundowicz SA; Gaddam S; Hovis CE; Green D; Gupta N; Higbee A; Bansal A; Rastogi A; Early D; Lightdale CJ; Sharma P
    Dig Dis Sci; 2013 Jun; 58(6):1703-9. PubMed ID: 23633158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.
    Kestens C; Offerhaus GJ; van Baal JW; Siersema PD
    Clin Gastroenterol Hepatol; 2016 Jul; 14(7):956-962.e1. PubMed ID: 26748222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.